Ganglioside immunostimulating complexes and uses thereof
CA 2293439 A1 · Owner: Cox, John Cooper · Inventors: Cox, John Cooper; Ronnberg, Bengt John Lennart; Sjolander, Sigrid Elisabet
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to an immunostimulating complex comprising one or more gangliosides and more particularly to an immunostimulating complex comprising at least one of the gangliosides GM2 GD2, GD3 or GT3. The present invention is useful inter alia, as a , prophylactic and/or therapeutic agent in the treatment of tumours and more , particularly, melanomas.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 12, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 12, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 12, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.